Non-small cell lung cancer with STK11/LKB1 mutation

Clinical trials for Non-small cell lung cancer with STK11/LKB1 mutation explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer with STK11/LKB1 mutation trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer with STK11/LKB1 mutation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for rare lung cancer mutation? daratumumab shows promise in early trial

Disease control Completed

This study tested a drug called daratumumab in 8 people with a specific genetic mutation (STK11/LKB1) in advanced non-small cell lung cancer who had already tried other treatments. The goal was to see if the drug could shrink tumors. The study was small and designed to find early…

Matched conditions: NON-SMALL CELL LUNG CANCER WITH STK11/LKB1 MUTATION

Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

Non-small cell lung cancer with STK11/LKB1 mutation

Get alerted when new Non-small cell lung cancer with STK11/LKB1 mutation trials appear

New hope for rare lung cancer mutation? daratumumab shows promise in early trial